Literature DB >> 27893323

ERCC1 as Predictor of Platinum Benefit in Non-Small-Cell Lung Cancer.

Sophie Postel-Vinay1, Jean-Charles Soria1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27893323     DOI： 10.1200/JCO.2016.70.5053

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

1.  Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification.

Authors:  Benedetta Pellegrino; Andrea Herencia-Ropero; Alba Llop-Guevara; Flaminia Pedretti; Alejandro Moles-Fernández; Cristina Viaplana; Guillermo Villacampa; Marta Guzmán; Olga Rodríguez; Judit Grueso; Jose Jiménez; Enrique J Arenas; Andrea Degasperi; João M L Dias; Josep V Forment; Mark J O'Connor; Olivier Déas; Stefano Cairo; Yinghui Zhou; Antonino Musolino; Carlos Caldas; Serena Nik-Zainal; Robert B Clarke; Paolo Nuciforo; Orland Díez; Xavier Serres-Créixams; Vicente Peg; Martín Espinosa-Bravo; Teresa Macarulla; Ana Oaknin; Joaquin Mateo; Joaquín Arribas; Rodrigo Dienstmann; Meritxell Bellet; Mafalda Oliveira; Cristina Saura; Sara Gutiérrez-Enríquez; Judith Balmaña; Violeta Serra
Journal:  Cancer Res       Date:  2022-04-15       Impact factor: 13.312

Review 2.  Excision repair of topoisomerase DNA-protein crosslinks (TOP-DPC).

Authors:  Yilun Sun; Sourav Saha; Wenjie Wang; Liton Kumar Saha; Shar-Yin Naomi Huang; Yves Pommier
Journal:  DNA Repair (Amst)       Date:  2020-03-07

3.  Evaluating the Prognostic Value of ERCC1 and Thymidylate Synthase Expression and the Epidermal Growth Factor Receptor Mutation Status in Adenocarcinoma Non-Small-Cell Lung Cancer.

Authors:  Chang-Sheng Lin; Tu-Chen Liu; Ji-Ching Lai; Shun-Fa Yang; Thomas Chang-Yao Tsao
Journal:  Int J Med Sci       Date:  2017-11-02       Impact factor: 3.738

Review 4.  Any Place for Immunohistochemistry within the Predictive Biomarkers of Treatment in Lung Cancer Patients?

Authors:  Véronique Hofman; Sandra Lassalle; Coraline Bence; Elodie Long-Mira; Sacha Nahon-Estève; Simon Heeke; Virginie Lespinet-Fabre; Catherine Butori; Marius Ilié; Paul Hofman
Journal:  Cancers (Basel)       Date:  2018-03-13       Impact factor: 6.639

5.  Cytidine deaminase enzymatic activity is a prognostic biomarker in gemcitabine/platinum-treated advanced non-small-cell lung cancer: a prospective validation study.

Authors:  Carmelo Tibaldi; Andrea Camerini; Marcello Tiseo; Francesca Mazzoni; Fausto Barbieri; Isabella Vittimberga; Matteo Brighenti; Luca Boni; Editta Baldini; Annalisa Gilli; Richard Honeywell; Myriam Chartoire; Godefridus J Peters; Elisa Giovannetti
Journal:  Br J Cancer       Date:  2018-11-08       Impact factor: 7.640

6.  Serum MicroRNAs Related with Chemoradiotherapy Resistance in Advanced-Stage Cervical Squamous Cell Carcinoma.

Authors:  Ying Han; Mei Liu; Ziyi Wang; Manni Huang; Ningzhi Xu; Lingying Wu
Journal:  Transl Oncol       Date:  2017-04-19       Impact factor: 4.243

7.  Low ERCC1 expression is a good predictive marker in lung adenocarcinoma patients receiving chemotherapy based on platinum in all TNM stages - a single-center study.

Authors:  Marina Piljić Burazer; Suzana Mladinov; Antonela Matana; Sendi Kuret; Joško Bezić; Merica Glavina Durdov
Journal:  Diagn Pathol       Date:  2019-09-14       Impact factor: 2.644
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.